Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resistance to anti-PD-1 in murine non-small cell lung cancer

By sjmartinez • September 27, 2024

Du Y, Salehi-Rad R, Zhang TH, Crosson WP, Abascal J, Chen D, Shi Y, Jiang H, Tseng YW, Ma X, Hong M, Wang S, Wang X, Tang K, Hu S, Li Y, Ni S, Cai Y, Tappuni S, Shen Y, Liu B, Sun R. Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resist a nce to anti-PD-1 in murine non-small cell lung cancer. Cancer Immunol Res. 2024 Sep 26. doi: 10.1158/2326-6066.CIR-23-1075. Epub ahead of print. PMID: 39325056.

Tags: Post Doc, Publications, Pulmonary, Critical Care & Sleep Medicine, Veterans Administration

Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM-3

Nooka AK, Strouse C, Larson SM, Lesokhin A, Varshavsky-Yanovsky A, Vesole DH, Koehne G, Soussou E, Sullivan ST, Cheng J, Raje N. Efficacy and safety[...]

A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity

Esquenazi A, Wein TH, Verduzco-Gutierrez M, Ayyoub Z, Page S, Harding S, Maisonobe P, Beneteau M, Patel A; DIRECTION study group. A Phase IV, Randomized,[...]

Socioeconomic status and the relationship of physical performance with activities of daily living among US older adults

Chang G, Malhotra R, Seligman B. Socioeconomic status and the relationship of physical performance with activities of daily living among US older adults. PLoS One.[...]